Altimmune, Inc. (FWB:3G0) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Derace L Schaffer Other companies: Lantheus Holdings, Inc. (Director · Mar 4, 2016 – Mar 3, 2020 · Past); American Caresource Holdings Inc (Director · Jul 20, 2010 – Jun 14, 2012 · Past); King Pharmaceuticals Inc (Director · May 14, 2010 – Jan 31, 2011 · Past) | Director · May 17, 2010 – Dec 28, 2017 · Past |
| Richard I Eisenstadt Other companies: Aytu BioPharma, Inc. (Chief Financial Officer · Mar 31, 2021 – Mar 31, 2021 · Past); Neos Therapeutics Inc (Chief Financial Officer · Mar 2, 2020 – Mar 19, 2021 · Past) | Chief Financial Officer · Dec 31, 2021 – Jan 30, 2024 · Past |
| Wayne Pisano Other companies: Oncolytics Biotech Inc. (Director · Since at least Jun 26, 2025); Provention Bio Inc (Director · Jul 3, 2018 – Apr 27, 2023 · Past) | Director · Since at least Aug 30, 2018 |
| Gregory L Weaver Other companies: Atossa Therapeutics, Inc. (Former EVP, CFO, & Director, Director · May 17, 2019 – Nov 15, 2023 · Past) | Chief Financial Officer · Since at least Nov 11, 2024 |
| John M. Gill Other companies: Tetralogic Pharmaceuticals Corp (Director · Dec 11, 2013 – Dec 31, 2013 · Past) | Director · Since at least Jun 11, 2013 |
| Alex Howarth | Director · Since at least Oct 27, 2026 |
| Catherine Angell Sohn | Director · Since at least Nov 5, 2026 |
| Christophe Arbet-Engels | Chief Medical Officer · Since at least Aug 3, 2026 |
| David Drutz | Director · May 4, 2017 – Aug 19, 2024 · Past |
| Diane K. Jorkasky | Director · Since at least Nov 5, 2026 |
| Francesca M Cook | SVP, Policy & Gov't Affairs · Dec 1, 2011 – Dec 8, 2014 · Past |
| Greg Weaver | Chief Financial Officer · Since at least Sep 15, 2025 |
| Jeffrey Michael Jones | COO · Mar 11, 2015 – Mar 11, 2015 · Past |
| Jerome Durso | President, Chief Executive Officer and Chairman Of The Board · Since at least Aug 13, 2026 |
| Joel McCleary | Director · Jun 23, 2010 – Dec 31, 2014 · Past |
| Klaus Schafer | Director · Since at least May 4, 2017 |
| Linda M. Richardson | Chief Commercial Officer · Since at least Nov 6, 2025 |
| Matthew Scott Harris | Chief Medical Officer · Since at least Sep 9, 2019 |
| Mitchel Sayare | Director · Since at least Oct 27, 2026 |
| Peter Greenleaf | Director · Since at least Oct 27, 2026 |
| Philip Hodges | Director · Since at least Nov 4, 2026 |
| Philip Hodges | Director · Since at least May 4, 2017 |
| Richard Thomas Menziuso | Principal Accounting Officer · Since at least Nov 18, 2026 |
| Robin E. Abrams | Chief Legal Officer · Since at least Nov 6, 2025 |
| Scot Roberts | Chief Scientific Officer · Since at least May 4, 2017 |
| Teri Lawver | Director · Since at least Feb 25, 2025 |
| Thomas Richard Fuerst | EVP, Chief Scientific Officer · Apr 5, 2010 – Dec 1, 2011 · Past |